Changes in antibody titer after four and five doses of the SARS‐CoV‐2 vaccine in Japanese post‐kidney transplant patients

Author:

Fujieda Kumiko1ORCID,Tanaka Akihito1,Kikuchi Ryosuke23,Takai Nami4,Saito Shoji1,Yasuda Yoshinari1,Sano Yuta5,Kato Masashi5,Furuhashi Kazuhiro1ORCID,Maruyama Shoichi6

Affiliation:

1. Department of Nephrology Nagoya University Hospital Nagoya Japan

2. Department of Medical Technique Nagoya University Hospital Nagoya Japan

3. Division of Clinical Laboratory Gifu University Hospital Gifu Japan

4. Department of Nursing Nagoya University Hospital Nagoya Japan

5. Department of Urology Nagoya University Graduate School of Medicine Nagoya Japan

6. Department of Nephrology Nagoya University Graduate School of Medicine Nagoya Japan

Abstract

AbstractIntroductionImmunosuppressed patients exhibit low antibody acquisition rates following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination. Kidney transplant recipients previously exhibited low antibody acquisition rates after two vaccine doses, which increased after the third dose. We evaluated antibody titers of Japanese post‐kidney transplant patients after the fourth and fifth vaccinations.MethodsAntibody titers for SARS‐CoV‐2 spike protein were measured between 3 weeks and 3 months after the fourth or fifth vaccination.ResultsIncreased antibody acquisition rates were observed after the fourth (75.0% antibody‐positive) and fifth (81.5% antibody‐positive) vaccinations. The antibody‐acquired group after the fourth vaccination exhibited a higher body mass index and estimated glomerular filtration rate (eGFR) than the non‐acquired group. A higher eGFR was associated with antibody acquisition after the fifth vaccination.ConclusionIn Japanese post‐kidney transplant patients, the antibody acquisition rate increased with each vaccine additional dose. Additional vaccinations are recommended to protect against SARS‐CoV‐2 infection.

Publisher

Wiley

Reference33 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3